Pinnacle Associates Ltd. Holds $6.94 Million in PTC Therapeutics, Inc.

PTC Stock

PTC Therapeutics, Inc. (PTCT:NSD) saw a reduction in its holdings by Pinnacle Associates Ltd., which sold 3,615 shares of the PTC stock during the fourth quarter of 2022, according to its most recent 13F filing with the Securities and Exchange Commission. The fund’s ownership in PTC Therapeutics, worth $6,936,000, represents a decrease of 2.0% at the end of the quarter.

Other institutional investors have bought and sold shares of the company, including MetLife Investment Management LLC, ProShare Advisors LLC, Diversified Trust Co, Altshuler Shaham Ltd, and Nisa Investment Advisors LLC.

 

PTC Stock Analysis:

It has been the subject of a number of analyst reports, with an average rating of “Hold” and an average price target of $49.55.

PTC stock performance shows a 1-year low of $25.01 and a 1-year high of $55.58, with a 50-day moving average price of $46.16 and a two-hundred day moving average price of $44.13.

PTCT Ratings by Stock Target Advisor

Company Profile:

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders.

Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases.

PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Top Trending Stocks

AVG Analyst Rating STA Analysis
StockTargetAdvisor
Buy
StockTargetAdvisor
Slightly Bullish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Slightly Bullish
StockTargetAdvisor
Buy
StockTargetAdvisor
Slightly Bullish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Bullish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Slightly Bullish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Slightly Bullish
StockTargetAdvisor
Strong Buy
StockTargetAdvisor
Slightly Bullish
N/A N/A
N/A N/A
StockTargetAdvisor
Buy
StockTargetAdvisor
Slightly Bullish
Ad
Ad

Leave a Reply

Your email address will not be published. Required fields are marked *